Brigitte Dreyfus

1.6k total citations
37 papers, 1.1k citations indexed

About

Brigitte Dreyfus is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Brigitte Dreyfus has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 17 papers in Pathology and Forensic Medicine and 15 papers in Immunology. Recurrent topics in Brigitte Dreyfus's work include Chronic Lymphocytic Leukemia Research (25 papers), Lymphoma Diagnosis and Treatment (17 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Brigitte Dreyfus is often cited by papers focused on Chronic Lymphocytic Leukemia Research (25 papers), Lymphoma Diagnosis and Treatment (17 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Brigitte Dreyfus collaborates with scholars based in France, United States and Germany. Brigitte Dreyfus's co-authors include Bruno Cazin, M Leporrier, Philippe Travade, B Desablens, Karim Maloum, J. Jaubert, Guillaume Dighiero, Jacques‐Louis Binet, Maurice Navarro and G. Lepeu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Brigitte Dreyfus

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Dreyfus France 10 887 705 398 240 121 37 1.1k
Loïc Ysebaert France 15 914 1.0× 783 1.1× 445 1.1× 430 1.8× 308 2.5× 57 1.4k
Carol Burian United States 9 605 0.7× 418 0.6× 303 0.8× 58 0.2× 241 2.0× 16 799
E Krykowski Poland 11 402 0.5× 375 0.5× 191 0.5× 68 0.3× 193 1.6× 38 583
Maria Luisa Guerrera United States 13 712 0.8× 581 0.8× 347 0.9× 198 0.8× 192 1.6× 53 937
Natali Pflug Germany 13 446 0.5× 375 0.5× 217 0.5× 109 0.5× 223 1.8× 27 681
Maria Goldaniga Italy 16 302 0.3× 292 0.4× 141 0.4× 248 1.0× 157 1.3× 39 647
U. Winkler Germany 10 269 0.3× 308 0.4× 364 0.9× 75 0.3× 214 1.8× 12 785
Antonella Teramo Italy 16 282 0.3× 271 0.4× 402 1.0× 77 0.3× 144 1.2× 38 722
NE Hansen Denmark 11 273 0.3× 176 0.2× 249 0.6× 259 1.1× 118 1.0× 16 715
Goretta Bonacorsi Italy 16 204 0.2× 215 0.3× 137 0.3× 110 0.5× 276 2.3× 34 710

Countries citing papers authored by Brigitte Dreyfus

Since Specialization
Citations

This map shows the geographic impact of Brigitte Dreyfus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Dreyfus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Dreyfus more than expected).

Fields of papers citing papers by Brigitte Dreyfus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Dreyfus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Dreyfus. The network helps show where Brigitte Dreyfus may publish in the future.

Co-authorship network of co-authors of Brigitte Dreyfus

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Dreyfus. A scholar is included among the top collaborators of Brigitte Dreyfus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Dreyfus. Brigitte Dreyfus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Défossez, Gautier, Stéphanie Guidez, Camille Laurent, et al.. (2020). R-CHOP appears to be the best first-line treatment for second primary diffuse large B cell lymphoma: a cancer registry study. Annals of Hematology. 99(7). 1605–1613.
2.
Dreyfus, Brigitte, et al.. (2019). False paraprotein-induced hypoglycemia in the measurement of glucose by the hexokinase method. Annales de biologie clinique. 77(4). 439–445. 3 indexed citations
3.
Ghez, David, Caroline Protin, Marine Baron, et al.. (2018). Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib. Blood. 131(17). 1955–1959. 205 indexed citations
4.
Guidez, Stéphanie, Cécile Tomowiak, Brigitte Dreyfus, et al.. (2018). Oral CHOP-like Chemotherapy in Elderly Patients with High-Grade Non Hodgkin B Cell Lymphoma. Blood. 132(Supplement 1). 4231–4231. 1 indexed citations
5.
6.
Bridoux, Frank, Edouard Randriamalala, Éstelle Desport, et al.. (2011). Fanconi syndrome and chronic kidney disease in paroxysmal nocturnal hemoglobinuria: effect of eculizumab therapy. Clinical Nephrology. 78(10). 316–321. 5 indexed citations
7.
Maloum, Karim, Catherine Settegrana, Élise Chapiro, et al.. (2009). IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. Annals of Hematology. 88(12). 1215–1221. 23 indexed citations
8.
Cazin, Bruno, Marine Diviné, Stéphane Leprêtre, et al.. (2008). High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia. British Journal of Haematology. 143(1). 54–59. 13 indexed citations
9.
Tournilhac, Olivier, V. Leblond, Reza Tabrizi, et al.. (2003). Transplantation in Waldenstrom's macroglobulinemia—the French experience. Seminars in Oncology. 30(2). 291–296. 38 indexed citations
10.
Leporrier, M, Sylvie Chevret, Bruno Cazin, et al.. (2001). Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood. 98(8). 2319–2325. 298 indexed citations
11.
Dighiero, Guillaume, Karim Maloum, B Desablens, et al.. (1998). Chlorambucil in Indolent Chronic Lymphocytic Leukemia. New England Journal of Medicine. 338(21). 1506–1514. 323 indexed citations
12.
Brizard, Françoise, Brigitte Dreyfus, François Guilhot, J Tanzer, & André Brizard. (1997). 11q13 Rearrangement in B Cell Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 25(5-6). 539–543. 5 indexed citations
13.
Brizard, A., Franck Morel, Jean‐Claude Lecron, et al.. (1994). Proliferative Response of B Chronic Lymphocytic Leukemia Lymphocytes Stimulated with IL2 and Soluble CD23. Leukemia & lymphoma. 14(3-4). 311–318. 9 indexed citations
14.
15.
Brizard, A., Françoise Brizard, M Lessard, et al.. (1993). Improvement of cytogenetic results in B-cell chronic lymphocytic leukemia using immuno-purified leukemic cells.. PubMed. 35(1). 103–5. 3 indexed citations
16.
Guilhot, François, Brigitte Dreyfus, André Brizard, Jean‐Loup Huret, & J Tanzer. (1991). Cytogenetic Remissions in Chronic Myelogenous Leukemia Using Interferon Alpha-2a and Hydroxyurea with or without Low-Dose Cytosine Arabinoside. Leukemia & lymphoma. 4(1). 49–55. 39 indexed citations
17.
Guilhot, François, Brigitte Dreyfus, A. Brizard, et al.. (1990). Cytogenetics and molecular analysis in chronic myelogenous leukemia patients treated by interferon and chemotherapy.. PubMed. 32(5). 287–8. 2 indexed citations
18.
Sébahoun, G, Sultan C, & Brigitte Dreyfus. (1975). [Erythroleukemia. Apropos of 13 cases and a review of the literature].. PubMed. 125(8-9). 633–9. 1 indexed citations
19.
Gluckman, E, P Veyssier, Sultan C, & Brigitte Dreyfus. (1971). [Blood disorders due to thiamphenicol. Apropos of 3 cases].. PubMed. 79(30). 1385–8. 1 indexed citations
20.
Bn, Halpern, et al.. (1957). [Inhibition by cortisone of anti-microbial immunity and of formation of gamma globulin in young rats].. PubMed. 151(3). 436–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loïc Ysebaert Breakdown of academic impact, for papers by Carol Burian Breakdown of academic impact, for papers by E Krykowski Breakdown of academic impact, for papers by Maria Luisa Guerrera Breakdown of academic impact, for papers by Natali Pflug Breakdown of academic impact, for papers by Maria Goldaniga Breakdown of academic impact, for papers by U. Winkler Breakdown of academic impact, for papers by Antonella Teramo Breakdown of academic impact, for papers by NE Hansen Breakdown of academic impact, for papers by Goretta Bonacorsi
Rankless by CCL
2026